The goal of this Phase 1 clinical trial is to evaluate the safety and feasibility of nivolumab-IRDye800CW (nivo800) as a molecular imaging agent in adults with…

HnsccHead and NeckSquamous Cell Cancer+8 more

~Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT07460765

Observational

Pilot Study Assessment of Bone Mineral Density Changes During Treatment With Anti-PD-1 Immunotherapy Agents

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment and work by blocking protein interactions that normally prevent the immune system from…

Breast Cancer (Triple Negative Breast Cancer (TNBC))Renal Cell Carcinoma (Kidney Cancer)Melanoma (Skin Cancer)+5 more

~Estimated

~$10 – $7,500

Jessica Mezzanotte SharpeNCT07555210